These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32701968)

  • 1. Opportunities for improved HIV prevention and treatment through budget optimization in Eswatini.
    Minnery M; Mathabela N; Shubber Z; Mabuza K; Gorgens M; Cheikh N; Wilson DP; Kelly SL
    PLoS One; 2020; 15(7):e0235664. PubMed ID: 32701968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa: a health economic and modelling analysis.
    Cambiano V; Johnson CC; Hatzold K; Terris-Prestholt F; Maheswaran H; Thirumurthy H; Figueroa C; Cowan FM; Sibanda EL; Ncube G; Revill P; Baggaley RC; Corbett EL; Phillips A;
    J Int AIDS Soc; 2019 Mar; 22 Suppl 1(Suppl Suppl 1):e25243. PubMed ID: 30907498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.
    Njeuhmeli E; Forsythe S; Reed J; Opuni M; Bollinger L; Heard N; Castor D; Stover J; Farley T; Menon V; Hankins C
    PLoS Med; 2011 Nov; 8(11):e1001132. PubMed ID: 22140367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stepped-wedge randomised trial on the impact of early ART initiation on HIV-patients' economic outcomes in Eswatini.
    Steinert JI; Khan S; Mlambo K; Walsh FJ; Mafara E; Lejeune C; Wong C; Hettema A; Ogbuoji O; Vollmer S; De Neve JW; Mazibuko S; Okello V; Bärnighausen T; Geldsetzer P
    Elife; 2020 Aug; 9():. PubMed ID: 32831169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost of Voluntary Medical Male Circumcision in South Africa.
    Tchuenche M; Palmer E; Haté V; Thambinayagam A; Loykissoonlal D; Njeuhmeli E; Forsythe S
    PLoS One; 2016; 11(10):e0160207. PubMed ID: 27783612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
    Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
    Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
    Shattock AJ; Benedikt C; Bokazhanova A; Đurić P; Petrenko I; Ganina L; Kelly SL; Stuart RM; Kerr CC; Vinichenko T; Zhang S; Hamelmann C; Manova M; Masaki E; Wilson DP; Gray RT
    PLoS One; 2017; 12(2):e0169530. PubMed ID: 28207809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and impacts of scaling up voluntary medical male circumcision in Tanzania.
    Menon V; Gold E; Godbole R; Castor D; Mahler H; Forsythe S; Ally M; Njeuhmeli E
    PLoS One; 2014; 9(5):e83925. PubMed ID: 24802022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV testing and counselling couples together for affordable HIV prevention in Africa.
    Wall KM; Inambao M; Kilembe W; Karita E; Vwalika B; Mulenga J; Parker R; Sharkey T; Sonti D; Tichacek A; Hunter E; Yohnka R; Abdallah JF; Thior I; Pulerwitz J; Allen S
    Int J Epidemiol; 2019 Feb; 48(1):217-227. PubMed ID: 30358840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budget impact analysis of HIV testing in the VA healthcare system.
    Anaya HD; Chan K; Karmarkar U; Asch SM; Bidwell Goetz M
    Value Health; 2012 Dec; 15(8):1022-8. PubMed ID: 23244803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
    Haacker M; Fraser-Hurt N; Gorgens M
    PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.
    van de Vijver DAMC; Richter AK; Boucher CAB; Gunsenheimer-Bartmeyer B; Kollan C; Nichols BE; Spinner CD; Wasem J; Schewe K; Neumann A
    Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.
    Granich RM; Gilks CF; Dye C; De Cock KM; Williams BG
    Lancet; 2009 Jan; 373(9657):48-57. PubMed ID: 19038438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.
    Vassall A; Pickles M; Chandrashekar S; Boily MC; Shetty G; Guinness L; Lowndes CM; Bradley J; Moses S; Alary M; ; Vickerman P
    Lancet Glob Health; 2014 Sep; 2(9):e531-e540. PubMed ID: 25304420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.
    Colin X; Lafuma A; Costagliola D; Smets E; Mauskopf J; Guillon P
    Pharmacoeconomics; 2010; 28 Suppl 1():183-97. PubMed ID: 21182351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
    Smith JA; Sharma M; Levin C; Baeten JM; van Rooyen H; Celum C; Hallett TB; Barnabas RV
    Lancet HIV; 2015 Apr; 2(4):e159-68. PubMed ID: 25844394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography.
    Hankins C; Warren M; Njeuhmeli E
    PLoS One; 2016; 11(10):e0160699. PubMed ID: 27783613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.